Type 1 Diabetes – Practical approaches to insulin Gla-300 usage
SA paediatric experts present the clinical and real-world evidence on the use of insulin glargine-300 in Type 1 Diabetes Mellitus (T1DM)
Learning objectives
You will learn from the five presented T2DM cases:
- The importance of choosing an appropriate insulin regimen that accommodates the individual needs of children with type 1 diabetes (T1DM)
- Insight into the unique needs of the paediatric population with T1DM
- The impacts of the high burden of diabetes self-management on clinical outcomes and quality of life
- How technological advances are driving revised T1DM treatment goals and mitigating the burden of diabetes self-management.
ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record 1 CPD point from the live webinar, invalidating any additional CPD points from the report. Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don't upload these yourself.
To access this module, please register or login: